Skip to main content
. 2022 Oct 6;49(1):11–23. doi: 10.1093/schbul/sbac138

Table 1.

Patient and Study Characteristics

First Author and Cohort Year Cohort Size Exp (Participants) Cohort Size Con (Participants) Rate Ratio FU (Weeks) Blinding Mean Age (Years) Mean DOI (Years) Patient Type Male Percentage Reduction Period (Weeks) Medication Type Pre Dose (mg) Post Dose (mg) Reduction Style Relapse Definition
Diamond38 1960 20 20 3,7 26 Yes 46,6 11,0 Inpatients nd 0 Oral 8,5 0,0 Abrupt Clinical Judgment
Blackburn39 1961 14 25 4,8 16 No nd nd Inpatients 100 0 Oral nd 0,0 Abrupt Rated on scales
Freeman40 1962 46 48 2,3 26 Yes 41,1 13,0 Inpatients nd 0 Oral 4,6 0,0 Abrupt Clinical Judgment
Whittaker 141 1963 13 6 2,3 10 No 50,2 16,0 Outpatients 100 0 Oral 6,0 0,0 Abrupt Clinical Judgment
Whittaker 241 1963 13 7 2,7 10 Yes 49,5 15,0 Outpatients 100 0 Oral 6,0 0,0 Abrupt Clinical Judgment
Marjerrison42 1964 171 44 10,9 22 Yes 47,0 20,0 Inpatients 48 0 Oral nd 0,0 Abrupt Rated on scales
Caffey 143 1964 89 44 9,9 16 Yes 40,0 10,0 Inpatients 100 1 Oral 7,5 0,0 Gradual Clinical Judgment
Caffey 243 1964 31 26 3,2 16 Yes 40,0 10,0 Inpatients 100 1 Oral 7,5 4,3 Gradual Clinical Judgment
Melnyk44 1966 16 9 21,0 6 Yes 42,8 12,0 Inpatients 65 0 Oral 7,0 0,0 Abrupt Clinical Judgment
Garfield45 1966 20 20 2,8 22 Yes 42,6 11,0 Inpatients 0 1 Oral 12,8 0,0 Gradual Clinical Judgment
Morton46 1968 20 20 2,8 26 Yes nd nd nd 100 0 nd nd 0,0 Abrupt Clinical Judgment
Rassidakis47 1970 13 13 1,7 39 No 49,3 24,0 Inpatients 43 0 nd nd 0,0 Abrupt Clinical Judgment
Baro48 1970 43 41 27,0 10 Yes nd nd Inpatients 100 1 LAI 50,1 0,0 Gradual Clinical Judgment
Hershon49 1972 11 11 4,5 16 Yes 55,1 nd Inpatients 52 1 LAI 11,3 0,0 Gradual Clinical Judgment
Ota50 1973 49 49 4,0 13 Yes 42,9 nd Inpatients 55 0 Oral 7,5 0,0 Abrupt Clinical Judgment
Andrews51 1976 17 14 4,9 42 Yes 53,8 nd Inpatients 100 0 Oral 4,6 0,0 Abrupt Clinical Judgment
Lonowski52 1978 25 23 0,9 15 Yes 47,11 12,2 Inpatients 56 15 LAI 6,6 1,4 Gradual Rated on scales
Levine 153 1980 27 6 nd 15 No 31,2 nd Inpatients 46 nd Oral 24,2 0,0 Abrupt Clinical Judgment
Levine 253 1980 23 11 3,3 15 No 32,1 nd Inpatients 52 nd LAI 12,4 0,0 Gradual Clinical Judgment
Lehmann54 1980 20 20 2,0 24 Yes 38,2 9,8 nd 68 2 LAI 270,0 30,0 Gradual Clinical Judgment
Cheung55 1981 13 15 3,9 78 Yes 39,6 11,0 Outpatients 43 0 Oral 3.3 0,0 Abrupt Clinical Judgment
Odejide56 1982 27 26 2,8 52 Yes nd nd Outpatients nd 6 LAI 20,0 0,0 Gradual Rated on scales
Lehmann57 1983 60 56 3,0 48 No 47,7 nd Outpatients 49 nd Oral 7,3 1,5 Gradual Clinical Judgment
Johnson58 1983 63 62 7,6 78 No 32,0 nd Outpatients 52 2 LAI nd 0,0 Gradual Rated on scales
Kane59 1983 62 32 11,9 52 Yes 29,0 6,0 Inpatients nd 3 LAI 20,0 2,0 Gradual Clinical Judgement
Wistedt60 1983 16 22 1,7 24 Yes 44,4 11,7 Outpatients 50 3 LAI 11,0 0,0 Gradual Rated on scales
Channabasavanna61 1987 14 14 13,3 12 Yes 36,0 11,0 Outpatients 64 0 Oral 6,1 0,0 Abrupt Clinical Judgment
Cookson62 1987 28 31 3,0 44 Yes 46,0 14,0 Inpatients 67 2 LAI nd >0 Gradual Rated on scales
Johnson63 1987 9 9 1,5 52 Yes 40,0 10,0 Outpatients 46 2 LAI nd >0 Gradual Rated on scales
Hogarthy64 1988 30 25 1,3 54 Yes 28,3 7,0 Outpatients 57 2 LAI 25,8 4,6 Gradual Rated on scales
Faraone65 1989 22 7 17,0 26 Yes nd nd Outpatients 100 5 Oral nd >0 Gradual Clinical Judgment
Sampath66 1992 12 12 1,9 12 Yes 57,6 31,0 Inpatients nd 2 LAI 40,0 0,0 Gradual Rated on scales
Inderbitzin67 1994 20 17 1,3 30 Yes 41,2 18,0 Outpatients 73 22 LAI 27,3 13,8 Gradual Clinical Judgment
Hogarthy68 1995 38 41 0,2 13 Yes 33,7 9,7 Outpatients 66 2 LAI 22,3 12,6 Gradual Clinical Judgment
Huttunen 69 1996 9 10 1,1 104 No nd nd Outpatients 53 4 Oral nd 4,0 Gradual Clinical Judgment
Hirschowitz 170 1997 6 8 2,7 52 Yes 48,0 24,2 Inpatients 100 2 Oral 18,3 1,0 Gradual Rated on scales
Hirschowitz 2 70 1997 8 8 0,5 52 Yes 43,1 23,2 Inpatients 75 2 Oral 20,0 11,0 Gradual Rated on scales
Schooler71 1997 106 107 1,2 104 Yes 29,6 21,1 Inpatients 66 2 LAI 37,1 16,3 Gradual Rated on scales
Carpenter72 1999 25 25 1,6 54 Yes 36,2 13,0 Outpatients 60 6 LAI 30 10,0 Gradual Rated on scales
Volavka73 2000 11 12 1,1 16 Yes 40,2 20,4 Inpatients 87 12 Oral 32,9 19,4 Gradual Clinical Judgment
Arato74 2002 71 206 1,8 52 Yes 48,8 22,0 Inpatients 83 0 Oral nd 0,0 Abrupt Rated on scales
Khazaie75 2005 25 25 1,2 54 Yes 34,0 12,0 Outpatients 72 6 LAI 20,7 10,0 Gradual Rated on scales
Ushida76 2006 17 17 nd 24 Yes 40,1 15,8 Outpatients 53 12 Oral 14 8,0 Gradual Clinical Judgment
Kramer77 2007 55 56 2,1 34 Yes 40,7 12,6 nd 51 0 Oral 10,8 0,0 Abrupt Rated on scales
Rouillon78 2008 49 48 2,0 26 No 39,5 nd Outpatients 65 nd Oral 7,4 5,3 Gradual Clinical Judgment
Hough79 2008 140 133 2,7 46 Yes 39,1 11,9 nd 54 4 LAI 6,6 0,0 Gradual Rated on scales
Kane 180 2010 203 205 2,3 24 Yes 37,7 nd Outpatients 60 0 Oral 2,8 0,2 Abrupt Rated on scales
Kane 280 2010 144 133 4,5 24 Yes 39,5 nd Outpatients 67 0 Oral 2,8 1,4 Abrupt Rated on scales
Wang81 2010 245 129 2,6 52 No 32,0 6,4 Inpatients 45 8 Oral 4,3 2,1 Gradual Rated on scales
Takeuchi82 2013 31 30 1,0 24 No 40,9 15,5 Outpatients 58 4 Oral 4,8 2,5 Gradual Rated on scales
Yamanouchi83 2014 62 163 2,6 52 No 60,0 32,0 nd 57 24 Oral 20,0 15,0 Gradual Clinical Judgment
Zhou84 2018 37 38 0,7 52 Yes 44,3 5,0 Outpatients 60 16 Oral 5,4 3,2 Gradual Rated on scales
Ozawa85 2019 17 18 7,4 52 Yes 64,1 nd Inpatients 37 4 nd 7,0 2,8 Gradual Clinical Judgment
Huhn86 2021 10 8 0,4 14 Yes 44,7 16,8 Outpatients 55 14 Oral 5,8 3,5 Gradual Rated on scales
Total 2366 2205 1872 545
Mean 4.3 34,7 42,2 14,7 65,5 3,9 20,7 3,6
SD 5,2 22,5 7,9 6,4 21,6 5,7 40,5 6,2

Note: exp, experimental group = dose reduction or discontinuation condition; con, control group = maintenance condition; FU, follow-up period; DOI, duration of illness; nd, no data.